Literatuurlijst bij de column “Samenwerken”

De column van Dr. Mariëlle van Pampus “Uit de spreekkamer”: Samenwerken, uit de eerste editie van Inzicht 2024, heeft een literatuurlijst die bij de column hoort. Hierin wordt verwezen naar meerdere wetenschappelijke studies waarop dr. van Pampus haar column gebaseerd heeft. Hieronder kan je de complete literatuurlijst vinden.

Literatuur

  1. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979-88.
  2. Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015;385(9986):2492-501.
  3. Boers KE, Vijgen SM, Bijlenga D, van der Post JA, Bekedam DJ, Kwee A, et al. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). Bmj. 2010;341:c7087.
  4. Bijlenga D, Koopmans CM, Birnie E, Mol BW, van der Post JA, Bloemenkamp KW, et al. Health-related quality of life after induction of labor versus expectant monitoring in gestational hypertension or preeclampsia at term. Hypertens Pregnancy. 2011;30(3):260-74.
  5. Vijgen SM, Koopmans CM, Opmeer BC, Groen H, Bijlenga D, Aarnoudse JG, et al. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial). Bjog. 2010;117(13):1577-85.
  6. van Baaren GJ, Broekhuijsen K, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, et al. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II). Bjog. 2017;124(3):453-61.
  7. Chappell LC, Brocklehurst P, Green ME, Hunter R, Hardy P, Juszczak E, et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet. 2019;394(10204):1181-90.
  8. Bijlenga D, Boers K, Birnie E, Mol B, Vijgen S, van der Post J, et al. Maternal health-related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeks. Quality of Life Research. 2011:1-10.
  9. Vijgen SM, Boers KE, Opmeer BC, Bijlenga D, Bekedam DJ, Bloemenkamp KW, et al. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial). Eur J Obstet Gynecol Reprod Biol. 2013;170(2):358-63.
  10. van der Tuuk K, Koopmans CM, Groen H, Mol BW, van Pampus MG. Impact of the HYPITAT trial on doctors’ behaviour and prevalence of eclampsia in the Netherlands. Bjog. 2011;118(13):1658-60.
  11. Kallianidis AF, Schutte JM, Schuringa LEM, Beenakkers ICM, Bloemenkamp KWM, Braams-Lisman BAM, et al. Confidential enquiry into maternal deaths in the Netherlands, 2006–2018. Acta Obstetricia et Gynecologica Scandinavica. 2022;101(4):441-9.
  12. de Sonnaville CMW, Hukkelhoven CW, Vlemmix F, Groen H, Schutte JM, Mol BW, et al. Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands. Ultrasound Obstet Gynecol. 2020;55(1):58-67.